- A 2019 literature review found major gaps in understanding of shilajit’s mechanism of action, variability in efficacy, and toxicity profile.[1]
- Mechanisms such as antioxidant activity and effects on cellular energy rest mainly on laboratory and animal work.
- The few human mechanistic studies measured gene expression in muscle and skin, not health outcomes.[2][3]
- A plausible mechanism is a reason to run a trial, not evidence of benefit.
Three layers of shilajit science
- ChemistryWhat the material contains and how much it varies. Composition
- MechanismsWhat components do in cells and animals. Covered on this page.
- Human outcomesWhether people actually change. Evidence by topic
Claims often jump from the first layer straight to the third. Each step needs its own evidence.
Mechanism map
Scroll sideways to see the full table.| Proposed mechanism | Main evidence type | Human data? | Read more |
|---|---|---|---|
| Antioxidant activity | Laboratory and animal studies; a 2011 review criticised doses and missing controls in key work[4] | Markers only, in one trial[5] | Antioxidant activity |
| Mitochondria and cellular energy | Laboratory and animal studies | No direct human measurement | Mitochondria |
| DBPs and the urolithin link | Chemistry and laboratory work | No | Dibenzo-alpha-pyrones |
| Gene expression changes | Human biopsy studies in muscle and skin[2][3] | Yes, as biomarkers | Cellular research |
| Tau protein aggregation (cognition) | In vitro work summarised in a 2012 review[6] | No | Cognition |
| Mineral “carrier” / better absorption | Largely theoretical for shilajit | Not established | Bioavailability claims |
How a lab finding becomes a marketing claim
The pattern is familiar across supplements. A compound in shilajit shows an effect in cells at a concentration that may never be reached in the body. A rat study at a high dose shows a change in a marker. A product page then says shilajit “boosts energy at a cellular level”. Each step drops a qualification. When you read a mechanism claim, ask three questions: was it shown in people, at a realistic dose, and with the kind of product being sold?
Our pages on human vs animal evidence and evidence vs marketing claims go further.
What the human mechanistic studies measured
Two studies took tissue samples from people taking a standardised extract. One measured gene expression in skeletal muscle in adults with obesity.[2] The other measured skin gene expression and skin blood flow in women aged 30–65 over 14 weeks, reporting improved blood flow at the higher dose.[3] Both show that something changed at the tissue level. Neither measured strength, appearance, energy or any outcome a person would notice, so they sit in the “very limited” band of our evidence rating system.
Why processing and preparation matter scientifically
Much of the mechanism research used processed or standardised preparations. Heat, drying and extraction can change composition, so findings for one preparation may not hold for another. See does heat affect shilajit?, does drying change shilajit? and why research on one preparation may not apply to another.
Open questions
- Which components matter?No single active compound has been established.
- What reaches the bloodstream?Absorption of shilajit components in people is largely unmeasured.
- How much does source matter?Composition varies, but its effect on outcomes is unstudied.
- What is the safety profile long term?Identified as a gap in the literature.[1]
The running list is on evidence gaps.
Common questions
What is the active ingredient in shilajit?
No single active compound has been established. Fulvic acid and dibenzo-alpha-pyrones are the most studied candidates. See composition.
Is shilajit an antioxidant?
Laboratory and animal studies suggest antioxidant activity, and one human trial reported lower oxidative-stress markers. That is not the same as a proven health benefit.[5]
Does fulvic acid help absorb nutrients?
This “carrier” idea is common in marketing but has not been established in human studies of shilajit. See bioavailability claims.
Sources & further reading
Primary research, regulators and standards bodies are cited first. A source being listed here does not mean it supports every claim made by sellers; it supports the specific statement it is attached to.
- Shilajit (Mumie): current status of biochemical, therapeutic and clinical advances. Current Nutrition & Food Science 15(2), 2019. doi:10.2174/1573401313666170823160217. View source (opens in a new tab) [Review]
- Das A, et al.. The human skeletal muscle transcriptome in response to oral Shilajit supplementation. Journal of Medicinal Food 19(7):701–709, 2016. doi:10.1089/jmf.2016.0010; PMID 27414521. View source (opens in a new tab) [Human study (gene expression)]
- Das A, El Masry MS, Gnyawali SC, et al.. Skin transcriptome of middle-aged women supplemented with natural herbo-mineral shilajit shows induction of microvascular and extracellular matrix mechanisms. Journal of the American College of Nutrition 38(6):526–536, 2019. doi:10.1080/07315724.2018.1564088; PMID 31161927. View source (opens in a new tab) [Randomised controlled trial (biomarkers)]
- Wilson E, Rajamanickam GV, Dubey GP, et al.. Review on shilajit used in traditional Indian medicine. Journal of Ethnopharmacology 136(1):1–9, 2011. doi:10.1016/j.jep.2011.04.033; PMID 21530631. View source (opens in a new tab) [Review]
- Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: a randomized, double-blind, placebo-controlled trial. Phytomedicine 105:154334, 2022. doi:10.1016/j.phymed.2022.154334; PMID 35933897. View source (opens in a new tab) [Randomised controlled trial]
- Carrasco-Gallardo C, Guzmán L, Maccioni RB. Shilajit: a natural phytocomplex with potential procognitive activity. International Journal of Alzheimer’s Disease 2012:674142, 2012. doi:10.1155/2012/674142; PMID 22482077. View source (opens in a new tab) [Review (preclinical)]